INSP

Inspire Medical Systems, Inc. NYSE

Healthcare ·Medical - Devices ·US · inspiresleep.com

$56.70

Mkt Cap $1.7B

52w Low $48.30 7.3% of range 52w High $163.35

50d MA $56.96 200d MA $83.96

P/E (TTM) 11.4x

EV/EBITDA 40.6x

P/B 2.1x

Debt/Equity 0.0x

ROE 18.6%

P/FCF 34.5x

RSI (14) —

ATR (14) —

Beta 0.86

50d MA $56.96

200d MA $83.96

Avg Volume 1.2M

About

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a cl…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 11, 2026	AMC	0.69	1.65	+139.1%	67.94	-18.3%	-12.2%	-12.0%	-11.1%	-8.9%	-12.0%	-13.7%	—
Nov 3, 2025	AMC	-0.15	0.38	+353.3%	73.71	+8.5%	+15.3%	+12.4%	+13.7%	+11.0%	+16.8%	+82.8%	—
Aug 4, 2025	AMC	0.22	0.45	+104.5%	129.95	-31.7%	-32.4%	-39.6%	-40.7%	-39.1%	-38.7%	-34.1%	—
May 5, 2025	AMC	-0.23	0.10	+143.5%	158.74	-8.9%	+2.0%	-1.4%	-3.7%	-4.7%	-1.4%	-13.1%	—
Feb 10, 2025	AMC	0.74	1.15	+55.4%	180.99	-5.8%	+1.7%	+3.3%	+3.4%	+2.6%	-0.5%	-10.2%	—
Nov 4, 2024	AMC	0.08	0.60	+650.0%	192.71	+3.2%	+3.3%	+9.8%	+4.0%	+2.0%	+4.8%	+2.2%	—
Aug 6, 2024	AMC	-0.14	0.32	+328.6%	147.01	+17.0%	+28.1%	+27.7%	+31.4%	+32.8%	+30.7%	+34.2%	—
May 7, 2024	AMC	-0.63	-0.34	+46.0%	245.63	-27.1%	-33.5%	-29.0%	-31.7%	-35.0%	-35.4%	-36.3%	—
Feb 6, 2024	AMC	-0.09	0.49	+644.4%	226.00	-0.4%	-10.5%	-10.6%	-13.8%	-13.1%	-16.7%	-8.9%	—
Nov 7, 2023	AMC	-0.53	-0.29	+45.3%	161.74	-14.1%	-19.7%	-21.5%	-22.3%	-22.6%	-17.7%	-0.5%	—
Aug 1, 2023	AMC	-0.51	-0.41	+19.6%	290.93	+0.2%	-4.5%	-2.3%	-4.7%	-8.7%	-15.8%	-22.0%	—
May 2, 2023	AMC	-0.70	-0.53	+24.3%	257.30	+4.9%	+7.0%	+3.8%	+7.7%	+9.7%	+12.0%	+17.5%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 15	Truist	Maintains	Hold → Hold	—	$56.83	$56.83	+0.0%	-0.3%	-0.7%	+1.3%	+0.2%	-8.4%
Apr 13	Mizuho	Maintains	Outperform → Outperform	—	$54.02	$53.77	-0.5%	+1.7%	+5.2%	+4.9%	+4.5%	+6.6%
Apr 10	Stifel	Maintains	Buy → Buy	—	$56.69	$56.00	-1.2%	-4.7%	-3.1%	+0.2%	-0.1%	-0.4%
Apr 6	Evercore ISI	Maintains	Outperform → Outperform	—	$54.99	$56.41	+2.6%	-1.5%	-1.0%	-2.9%	+3.1%	-1.8%
Mar 5	Stifel	Maintains	Buy → Buy	—	$64.32	$62.49	-2.8%	-2.9%	-2.1%	-3.8%	-7.6%	-6.8%
Feb 13	Wolfe Research	Downgrade	Outperform → Peer Perform	—	$59.65	$59.64	-0.0%	+0.2%	+1.2%	+3.8%	+0.2%	-0.2%
Feb 12	Piper Sandler	Maintains	Overweight → Overweight	—	$67.94	$55.52	-18.3%	-12.2%	-12.0%	-11.1%	-8.9%	-12.0%
Feb 12	Jefferies	Maintains	Hold → Hold	—	$67.94	$55.52	-18.3%	-12.2%	-12.0%	-11.1%	-8.9%	-12.0%
Feb 12	Truist	Maintains	Hold → Hold	—	$67.94	$55.52	-18.3%	-12.2%	-12.0%	-11.1%	-8.9%	-12.0%
Feb 12	Wells Fargo	Downgrade	Overweight → Equal Weight	—	$67.94	$55.52	-18.3%	-12.2%	-12.0%	-11.1%	-8.9%	-12.0%
Feb 12	Baird	Downgrade	Outperform → Neutral	—	$67.94	$55.52	-18.3%	-12.2%	-12.0%	-11.1%	-8.9%	-12.0%
Feb 12	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$67.94	$55.52	-18.3%	-12.2%	-12.0%	-11.1%	-8.9%	-12.0%
Feb 12	Mizuho	Maintains	Outperform → Outperform	—	$67.94	$55.52	-18.3%	-12.2%	-12.0%	-11.1%	-8.9%	-12.0%
Jan 27	RBC Capital	Downgrade	Outperform → Sector Perform	—	$81.33	$79.20	-2.6%	+0.6%	+0.8%	-3.4%	-6.8%	-9.7%
Jan 14	Wells Fargo	Maintains	Overweight → Overweight	—	$92.46	$92.10	-0.4%	+0.6%	+4.3%	-0.2%	+2.2%	+4.0%
Jan 8	Truist	Maintains	Buy → Buy	—	$99.03	$97.99	-1.1%	-4.1%	-0.7%	-2.1%	-6.6%	-6.0%
Dec 23	UBS	Maintains	Neutral → Neutral	—	$97.93	$95.98	-2.0%	-3.0%	-2.3%	-2.5%	-4.3%	-5.5%
Dec 17	Mizuho	Maintains	Outperform → Outperform	—	$115.51	$117.95	+2.1%	+2.4%	-17.5%	-16.4%	-15.2%	-17.8%
Dec 17	RBC Capital	Maintains	Outperform → Outperform	—	$115.51	$117.95	+2.1%	+2.4%	-17.5%	-16.4%	-15.2%	-17.8%
Dec 16	JP Morgan	Maintains	Neutral → Neutral	—	$119.26	$120.91	+1.4%	-3.1%	-0.8%	-20.1%	-19.1%	-17.9%
Dec 8	Piper Sandler	Maintains	Overweight → Overweight	—	$136.81	$140.69	+2.8%	+5.2%	+2.7%	+2.4%	+0.4%	-4.5%
Dec 8	Oppenheimer	Upgrade	Perform → Outperform	—	$136.81	$140.69	+2.8%	+5.2%	+2.7%	+2.4%	+0.4%	-4.5%
Dec 4	Baird	Maintains	Outperform → Outperform	—	$134.75	$138.07	+2.5%	+3.9%	+1.5%	+6.9%	+4.3%	+3.9%
Dec 2	Morgan Stanley	Downgrade	Overweight → Equal Weight	—	$126.34	$125.08	-1.0%	+6.0%	+6.7%	+10.8%	+8.3%	+14.0%
Nov 26	Truist	Upgrade	Hold → Buy	—	$130.39	$130.61	+0.2%	-2.3%	-4.6%	-3.1%	+2.7%	+3.3%
Nov 25	Wolfe Research	Upgrade	Peer Perform → Outperform	—	$117.29	$120.48	+2.7%	+11.2%	+8.6%	+6.1%	+7.7%	+14.2%
Nov 24	Stifel	Upgrade	Hold → Buy	—	$89.87	$105.74	+17.7%	+30.5%	+45.1%	+41.7%	+38.4%	+40.6%
Nov 4	Piper Sandler	Maintains	Overweight → Overweight	—	$73.71	$80.01	+8.5%	+15.3%	+12.4%	+13.7%	+11.0%	+16.8%
Nov 4	Truist	Maintains	Hold → Hold	—	$73.71	$80.01	+8.5%	+15.3%	+12.4%	+13.7%	+11.0%	+16.8%
Nov 4	Wells Fargo	Upgrade	Equal Weight → Overweight	—	$73.71	$80.01	+8.5%	+15.3%	+12.4%	+13.7%	+11.0%	+16.8%
Nov 4	RBC Capital	Maintains	Outperform → Outperform	—	$73.71	$80.01	+8.5%	+15.3%	+12.4%	+13.7%	+11.0%	+16.8%
Nov 4	JP Morgan	Maintains	Neutral → Neutral	—	$73.71	$80.01	+8.5%	+15.3%	+12.4%	+13.7%	+11.0%	+16.8%
Oct 24	Jefferies	Downgrade	Buy → Hold	—	$80.17	$79.00	-1.5%	-3.3%	-2.5%	-3.7%	-6.2%	-8.9%
Oct 15	Truist	Maintains	Hold → Hold	—	$78.84	$78.72	-0.2%	+0.0%	-1.9%	-1.1%	+2.5%	+5.0%
Oct 7	Evercore ISI	Maintains	Outperform → Outperform	—	$76.37	$76.51	+0.2%	+0.6%	+2.8%	+4.9%	-1.6%	+1.7%
Sep 22	UBS	Downgrade	Buy → Neutral	—	$79.88	$77.67	-2.8%	-1.7%	-3.6%	-2.6%	-3.2%	-3.3%
Aug 15	Leerink Partners	Maintains	Market Perform → Market Perform	—	$84.58	$84.88	+0.4%	+3.8%	+4.4%	+6.5%	+10.0%	+8.3%
Aug 5	Stifel	Maintains	Hold → Hold	—	$129.95	$88.75	-31.7%	-32.4%	-39.6%	-40.7%	-39.1%	-38.7%
Aug 5	Lake Street	Maintains	Buy → Buy	—	$129.95	$88.75	-31.7%	-32.4%	-39.6%	-40.7%	-39.1%	-38.7%
Aug 5	KeyBanc Capital Markets	Downgrade	Overweight → Sector Weight	—	$129.95	$88.75	-31.7%	-32.4%	-39.6%	-40.7%	-39.1%	-38.7%
Aug 5	RBC Capital	Maintains	Outperform → Outperform	—	$129.95	$88.75	-31.7%	-32.4%	-39.6%	-40.7%	-39.1%	-38.7%
Aug 5	Piper Sandler	Maintains	Overweight → Overweight	—	$129.95	$88.75	-31.7%	-32.4%	-39.6%	-40.7%	-39.1%	-38.7%
Aug 5	JP Morgan	Downgrade	Overweight → Neutral	—	$129.95	$88.75	-31.7%	-32.4%	-39.6%	-40.7%	-39.1%	-38.7%
Aug 5	UBS	Maintains	Buy → Buy	—	$129.95	$88.75	-31.7%	-32.4%	-39.6%	-40.7%	-39.1%	-38.7%
Aug 5	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$129.95	$88.75	-31.7%	-32.4%	-39.6%	-40.7%	-39.1%	-38.7%
Aug 5	Truist	Downgrade	Buy → Hold	—	$129.95	$88.75	-31.7%	-32.4%	-39.6%	-40.7%	-39.1%	-38.7%
Aug 5	Leerink Partners	Maintains	Market Perform → Market Perform	—	$129.95	$88.75	-31.7%	-32.4%	-39.6%	-40.7%	-39.1%	-38.7%
Jul 22	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$125.14	$124.45	-0.6%	+3.4%	+5.1%	+2.8%	+3.0%	+4.5%
Jul 15	Morgan Stanley	Maintains	Overweight → Overweight	—	$130.26	$132.40	+1.6%	-1.7%	-2.1%	-1.8%	-2.6%	-3.9%
Jul 14	Leerink Partners	Maintains	Market Perform → Market Perform	—	$130.26	$130.00	-0.2%	+0.0%	-1.7%	-2.1%	-1.8%	-2.6%

Recent Filings

8-K · 7.01 ! Medium

Inspire Medical Systems, Inc. -- 8-K 7.01: Regulation FD Disclosure

Inspire Medical Systems is conducting investor outreach roadshow meetings in February-March 2026, with presentation materials available publicly, indicating management engagement with capital markets.

Feb 11

Data updated apr 25, 2026 3:47pm · Source: massive.com